Skip to main content
Premium Trial:

Request an Annual Quote

The FCC Values Data

Dan Vorhaus at the Genomics Law Report considers what the Federal Communications Commission's National Broadband Plan could mean for genomics and personalized medicine. In Section 10.4, he says, the FCC conjures the value of data and the importance of consumer access. "In focusing on the value of data the FCC clearly indicates that it’s interested in liberating all types of healthcare data — patient and provider, administrative, research and clinical — from the 'proprietary siloed' systems that do not communicate with one another and therefore cannot be easily exchanged, aggregated or analyzed," Vorhaus writes. Further, the FCC acknowledges the merits of dispersing genomic data, as it "could help researchers better understand the interplay of genetics and the environment." As far as access is concerned, Vorhaus points out that the FCC recognizes the importance of "consumers" having access to their healthcare data. "With seamless access to their raw health data including lab data and prescriptions, consumers could plug the information into specialized applications of their choice and get personalized solutions for an untold number of conditions," the plan reads.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.